Ignace Vergote

Researcher Next ID · RN-007575

Researcher · Medicine

Leuven, Belgium

Not currently recruitingFunding unknown

Research interests

Medicine

Biochemistry, Genetics and Molecular Biology

Ovarian cancer diagnosis and treatment

Endometrial and Cervical Cancer Treatments

PARP inhibition in cancer therapy

Intraperitoneal and Appendiceal Malignancies

BRCA gene mutations in cancer

ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma
International Journal of Gynecological Cancer · 2020 · https://doi.org/10.1136/ijgc-2020-002230
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
New England Journal of Medicine · 2019 · https://doi.org/10.1056/nejmoa1910962
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer
New England Journal of Medicine · 2019 · https://doi.org/10.1056/nejmoa1911361
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
New England Journal of Medicine · 2016 · https://doi.org/10.1056/nejmoa1611310
Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
New England Journal of Medicine · 2010 · https://doi.org/10.1056/nejmoa0908806

No projects listed.